Elderly patients with chronic lymphocytic leukaemia (CLL): predicting their survival and managing their disease with valproic acid and fludarabine
Chronic Lymphocytic Leukaemia (CLL) is a disease of B-lymphocytes that account for significant morbidity and mortality in mostly elderly patients (aged ≥ 70 years). The relative survival of patients with CLL has been shown to decrease with patient age, and this age-related reduction in survival w...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Informa Healthcare
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1993/23317 |